Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hunstein

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cellsM Pfreundschuh, B Dörken, W Brandeis, et al.
Bone Marrow Transplantation|January 1, 1993
Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factorsR Haas, S Hohaus, R Ehrhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|May 15, 1981
[Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)]A D Ho, W Hunstein, N Uhl, et al.
Experimental Hematology|January 1, 1993
Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantationR Haas, G Gericke, B Witt, et al.
Acta Haematologica|January 1, 1993
Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapyS Fruehauf, C Fiehn, R Haas, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1988
[A new approach in the treatment of metastatic melanoma: adoptive immunotherapy using lymphokine-activated killer cells and interleukin 2]U Keilholz, H Welters, R Dummer, et al.
Immunology Letters|January 31, 1989
Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) on normal peripheral B lymphocytes and B lymphoblastoid cell linesR Haas, S Hohaus, S Kiesel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patientsL H Trümper, A D Ho, G Wulf, et al.
Cancer|August 1, 1989
Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disordersU Keilholz, M Körbling, D Fehrentz, et al.
Research in Immunology|January 1, 1992
The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75)C Scheibenbogen, U Keilholz, M Richter, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cellsM Pfreundschuh, B Dörken, W Brandeis, et al.
Bone Marrow Transplantation|January 1, 1993
Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factorsR Haas, S Hohaus, R Ehrhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|May 15, 1981
[Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)]A D Ho, W Hunstein, N Uhl, et al.
Experimental Hematology|January 1, 1993
Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantationR Haas, G Gericke, B Witt, et al.
Acta Haematologica|January 1, 1993
Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapyS Fruehauf, C Fiehn, R Haas, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1988
[A new approach in the treatment of metastatic melanoma: adoptive immunotherapy using lymphokine-activated killer cells and interleukin 2]U Keilholz, H Welters, R Dummer, et al.
Immunology Letters|January 31, 1989
Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) on normal peripheral B lymphocytes and B lymphoblastoid cell linesR Haas, S Hohaus, S Kiesel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patientsL H Trümper, A D Ho, G Wulf, et al.
Cancer|August 1, 1989
Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disordersU Keilholz, M Körbling, D Fehrentz, et al.
Research in Immunology|January 1, 1992
The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75)C Scheibenbogen, U Keilholz, M Richter, et al.
Pageof 19